Cargando…
Thymosin β4 Improves Differentiation and Vascularization of EHTs
Induced pluripotent stem cells (iPSC) constitute a powerful tool to study cardiac physiology and represents a promising treatment strategy to tackle cardiac disease. However, iPSCs remain relatively immature after differentiation. Additionally, engineered heart tissue (EHT) has been investigated as...
Autores principales: | Ziegler, Tilman, Hinkel, Rabea, Stöhr, Andrea, Eschenhagen, Thomas, Laugwitz, Karl-Ludwig, le Noble, Ferdinand, David, Robert, Hansen, Arne, Kupatt, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278226/ https://www.ncbi.nlm.nih.gov/pubmed/28191018 http://dx.doi.org/10.1155/2017/6848271 |
Ejemplares similares
-
VEGF-B: a more balanced approach toward cardiac neovascularization?
por: Kupatt, Christian, et al.
Publicado: (2014) -
The Clinical Validation of Modulated Electro-Hyperthermia (mEHT)
por: Lee, Sun-Young, et al.
Publicado: (2023) -
Development of LTS and HTS Superconductors for Accelerator Magnets at EAS and EHTS
por: Krauth, H
Publicado: (2005) -
Systemic gene therapy with thymosin β4 alleviates glomerular injury in mice
por: Mason, William J., et al.
Publicado: (2022) -
Micro-RNA 92a as a Therapeutic Target for Cardiac Microvascular Dysfunction in Diabetes
por: Samak, Mostafa, et al.
Publicado: (2021)